PALIFERMIN
Showing 1 - 25 of 65
Leukemia, Multiple Myeloma, Myelodysplastic Syndrome Trial in New York (biological, procedure, radiation, drug)
Active, not recruiting
- Leukemia
- +3 more
- Palifermin
- +6 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 23, 2023
Myelodysplastic Syndrome, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in Bethesda, Minneapolis (biological, drug,
Recruiting
- Myelodysplastic Syndrome
- +4 more
- Rituximab
- +6 more
-
Bethesda, Maryland
- +1 more
Aug 20, 2022
Acute Myeloid Leukemia, Advanced MDS Trial in New York (Busulfan, Melphalan, Fludarabine, Anti-Thymocyte Globulin, Palifermin,
Completed
- Acute Myeloid Leukemia
- Advanced Myelodysplastic Syndromes
- Busulfan, Melphalan, Fludarabine, Anti-Thymocyte Globulin, Palifermin, Stem cell transplant
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Aug 27, 2021
T-cell Non-Hodgkin Lymphoma Trial in Boston (Cyclophosphamide, Doxorubicin, Vincristine)
Terminated
- T-cell Non-Hodgkin Lymphoma
- Cyclophosphamide
- +12 more
-
Boston, Massachusetts
- +1 more
Jan 26, 2023
X-linked Severe Combined Immunodeficiency (XSCID) Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)
Suspended
- X-linked Severe Combined Immunodeficiency (XSCID)
- Palifermin
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Leukemia Trial in Cleveland (Melphalan, Thiotepa, Fludarabine)
Recruiting
- Leukemia
- Melphalan
- +3 more
-
Cleveland, OhioUniversity Hospitals Seidman Cancer Center, Case Comprehensive C
Jan 24, 2022
Epidermolysis Bullosa Trial in Aurora, Chicago, New York (Palifermin, Fludarabine, Busulfan)
Terminated
- Epidermolysis Bullosa
- Palifermin
- +5 more
-
Aurora, Colorado
- +2 more
Aug 13, 2021
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (procedure, biological, drug,
Recruiting
- Acute Lymphoblastic Leukemia
- +3 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 12, 2023
Myeloma Trial in Houston (Palifermin, Dexamethasone, Gemcitabine)
Completed
- Myeloma
- Palifermin
- +6 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Apr 23, 2020
Relapsed Non Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in Maywood (Total body irradiation)
Completed
- Relapsed Non Hodgkin Lymphoma
- Refractory Non-Hodgkin Lymphoma
- Total body irradiation
-
Maywood, IllinoisPatrick Stiff, MD
Aug 19, 2019
Lymphoma Trial in Houston (Gemcitabine, Busulfan, Melphalan)
Completed
- Lymphoma
- Gemcitabine
- +4 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 13, 2019
X-Linked Combined Immunodeficiency Diseases Trial run by the NIAID (CD34+ HSCs transduced with the lentivirus vector, VSV-G
Unknown status
- X-Linked Combined Immunodeficiency Diseases
- CD34+ HSCs transduced with the lentivirus vector, VSV-G pseudotyped CL20-4i-EF1α-hγc-OPT
- +2 more
-
Bethesda, MarylandLaboratory of Host Defenses (LHD), National Institute of Allergy
Dec 3, 2019
Lymphoma Trial in Houston (Lenalidomide, Vorinostat, Gemcitabine)
Terminated
- Lymphoma
- Lenalidomide
- +12 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Nov 26, 2019
Multiple Sclerosis Trial in Cambridge (Palifermin, Alemtuzumab)
Terminated
- Multiple Sclerosis
- Palifermin
- Alemtuzumab
-
Cambridge, Cambridgeshire, United KingdomAddenbrooke's Hospital
Apr 26, 2019
Gastrointestinal Mucositis, Malignant Tumor Trial (Palifermin, Placebo)
Withdrawn
- Gastrointestinal Mucositis
- Malignant Neoplasm
- Palifermin
- Placebo
- (no location specified)
Aug 3, 2018
Colon Cancer, Oral Mucositis, Nurse's Role Trial in Bursa (Ankaferd Blood Stopper, Bicarbonate)
Enrolling by invitation
- Colon Cancer
- +3 more
- Ankaferd Blood Stopper
- Bicarbonate
-
Bursa, TurkeyBursa Uludag University
Jun 25, 2022
Mucositis Oral Trial (Benzydamine Hydrochloride, Solcoseryl and pumpkin seed oil)
Not yet recruiting
- Mucositis Oral
- Benzydamine Hydrochloride
- Solcoseryl and pumpkin seed oil
- (no location specified)
Aug 2, 2021
Oral Mucositis (Ulcerative) Trial in Navi Mumbai (Curcumin Lozenges, Placebo Lozenges)
Recruiting
- Oral Mucositis (Ulcerative)
- Curcumin Lozenges
- Placebo Lozenges
-
Navi Mumbai, Maharashtra, IndiaTata Memorial Centre
May 20, 2021
Hematopoietic and Lymphoid Cell Tumor, Hematopoietic Cell Transplantation Recipient Trial in Duarte (procedure, drug, other,
Withdrawn
- Hematopoietic and Lymphoid Cell Neoplasm
- Hematopoietic Cell Transplantation Recipient
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Dec 5, 2018
Oral Mucositis (Ulcerative) Trial in Navi Mumbai (Curcumin Lozenges)
Completed
- Oral Mucositis (Ulcerative)
- Curcumin Lozenges
-
Navi Mumbai, Maharashtra, IndiaTata Memorial Centre
Apr 30, 2021
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplasia Trial in Indianapolis (radiation, drug, biological)
Terminated
- Acute Myeloid Leukemia
- +3 more
- Total Body Irradiation
- +4 more
-
Indianapolis, IndianaIndiana University Cancer Center
Mar 12, 2018
Advanced Cancers, Lymphoma Trial in Houston (Azacitidine, Vorinostat, Gemcitabine)
Completed
- Advanced Cancers
- Lymphoma
- Azacitidine
- +9 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 14, 2020
Mucositis, Head Neck Cancer Trial (Placebo, palifermin, Radiotherapy)
Completed
- Mucositis
- Head and Neck Cancer
- Placebo
- +3 more
- (no location specified)
May 29, 2017
Head Neck Cancer, Mucositis, Pain Trial in Canada, United States (biological, drug, other, procedure, radiation)
Terminated
- Head and Neck Cancer
- +3 more
- palifermin
- +4 more
-
Scottsdale, Arizona
- +47 more
Nov 28, 2017
Oral Mucositis Due to Radiation Trial in Alexandria (vitamin D oral gel, Miconazole Topical Gel, BBC oral spray)
Unknown status
- Oral Mucositis Due to Radiation
- vitamin D oral gel
- +4 more
-
Alexandria, EgyptOutpatient clinic of Department of Clinical Oncology, Faculty of
Mar 12, 2020